Gryaznov Sergei 4
4 · MAIA Biotechnology, Inc. · Filed Jan 26, 2024
Insider Transaction Report
Form 4
Gryaznov Sergei
Chief Scientific Officer
Transactions
- Award
Stock Options
2024-01-24+100,000→ 100,000 totalExercise: $1.41Exp: 2034-01-24→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on January 24, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.